Product Description: SMU-CX1 is a specific TLR3 inhibitor (IC50: 0.11 μM) with IC50 ranging from 0.14-0.33 μM against multiple influenza A virus subtypes. SMU-CX1 inhibits the viral PB2 and NP proteins with an IC50 of 0.43 μM for SARS-CoV-2 activity. SMU-CX1 also inhibits inflammatory factors in host cells, including IFN-β, IP-10, and CCL-5[1].
Applications: COVID-19-anti-virus
Formula: C18H16N2O
References: [1]Pan Y, et al. Discovery of an ellipticine derivative as TLR3 inhibitor against influenza A virus and SARS-CoV-2. Bioorg Med Chem Lett. 2024 Mar 15;101:129672.
CAS Number: 10371-86-5
Molecular Weight: 276.33
Research Area: infection
Solubility: 10 mM in DMSO
Target: SARS-CoV;Toll-like Receptor (TLR)